Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of N-(Indol-3-ylglyoxylyl)benzylamine Derivatives Acting at the Benzodiazepine Receptor,-Reference-Cited by-同舟云学术

Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of N-(Indol-3-ylglyoxylyl)benzylamine Derivatives Acting at the Benzodiazepine Receptor,

Published:1996-01-01 Issue:26 Volume:39 Page:5083-5091
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Da Settimo Antonio¹,Primofiore Giampaolo¹,Da Settimo Federico¹,Marini Anna Maria¹,Novellino Ettore¹,Greco Giovanni¹,Martini Claudia¹,Giannaccini Gino¹,Lucacchini Antonio¹

Affiliation:

1. Dipartimento di Scienze Farmaceutiche and Istituto Policattedra di Discipline Biologiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy, and Dipartimento di Chimica Farmaceutica e Tossicologica, Università “Federico II” di Napoli, Via D. Montesano 49, 80131 Napoli, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm960240i

Reference58 articles.

1. GABAA Receptor Channels

2. Multiple benzodiazepine receptors: no reason for anxiety

3. Benzodiazepine receptors in rat brain

4. Benzodiazepine Receptor: Demonstration in the Central Nervous System

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking therapeutic potential: exploring indole scaffolds and their structural insights as pharmacophores in designing anti-breast cancer agents;Medicinal Chemistry Research;2024-06-12

2. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry;Pharmaceuticals;2023-07-12

3. Allosteric Modulators of Adenosine Receptors;Topics in Medicinal Chemistry;2022

4. The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities;Journal of Medicinal Chemistry;2021-03-25

5. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications;Frontiers in Pharmacology;2021-03-24